Evidence map›Paper›PMID 41025303›Full record

ArticleJournal of movement disorders2026

Conceptualizing a Personalized Care Pathway for Parkinson's Disease Using Wearable Sensors in Muslim Patients: The Ramadan Regime.

Vinod Metta, Huzaifa Ibrahim, Haidar Dafsari, Rajinder K Dhamija, Hani T S Benamer, Tom Loney, Mishal Abu Al-Melh, Hasna Hussain, Afsal Nalarekttil, Guy Chung-Faye and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of movement disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Vinod MettaDepartment of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Huzaifa IbrahimParkinson's Association United Arab Emirates, Dubai, UAE.
Haidar DafsariUniversity Hospital, Cologne, Germany.
Rajinder K DhamijaInstitute of Human Behaviour and Allied Sciences, Lady Hardinge Medical College and SSK Hospital, New Delhi, India.
Hani T S BenamerCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Tom LoneyCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Mishal Abu Al-MelhAl-Adan Hospital, Hadiya, Kuwait.
Hasna HussainParkinson's Foundation Centre of Excellence, King's College Hospital London, Dubai, UAE.
Afsal NalarekttilParkinson's Foundation Centre of Excellence, King's College Hospital London, Dubai, UAE.
Guy Chung-FayeDepartment of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.
Gloria TanjungDepartment of Neurology, EMG Group of Hospitals, Jakarta, Indonesia.
Bushra AlblooshiStemcell Association, Abu Dhabi, UAE.
Shaikha AlmazroueiStemcell Association, Abu Dhabi, UAE.
Bassam DarwishBalsam Healthcare Development, Dubai, UAE.
Mohamed Al MheiriDubai Health Authority (DHA), Dubai, UAE.
Mohamed ElmahdyBahrain Specialist Hospital, Al Manama, Bahrain.
Rukmini MridulaInstitute of Movement Disorders and Parkinson's Centre, Yashodha Hospitals, Hyderabad, India.
Sai Sampath KumarInstitute of Movement Disorders and Parkinson's Centre, Narayana Insititute of Medical sciences, Nellore, India.
Vinay GoyalInstitute of Movement Disorders and Parkinson's Centre, Medanta Hospitals, Delhi, India.
Karolina Popławska-DomaszewiczDepartment of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Cristian Falup PecurariuDepartment of Neurology, Transylvania University of Brasov, Brasov, Romania.
Prashanth KukleInstitute of Movement Disorders and Parkinson's Centre, Bengaluru, India.
Jacob ChackoWellcare Hospital, Kerala, India.
Rupam BorgohainInstitute of Movement Disorders and Parkinson's Centre, Yashodha Hospitals, Hyderabad, India.
Kallol Ray ChaudhuriDepartment of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveParkinson's disease (PD) affects approximately 2% of individuals over the age of 60. With more than two billion Muslims observing Ramadan, individuals with PD encounter specific challenges, such as deteriorating motor skills, sleep disturbances, and an increased risk of falls during fasting.

methodsOur study focused on 75 patients with idiopathic PD divided into two groups: the Ramadan Regime group, which consisted of 50 patients whose medication was adjusted to twice daily at Suhoor and Iftar, and the Nontreatment group, which included 25 patients who abstained from medication for religious reasons. Both groups were instructed to wear a Parkinson's KinetiGraph (PKG) wrist device.

resultsThe study findings revealed that motor function worsened in the Nontreatment group (p<0.001) but improved in the Ramadan Regime group (p=0.007). Daytime sleepiness also significantly increased in the Nontreatment group (p<0.001).

conclusionOverall, the findings suggest that the Ramadan regime significantly enhances patient health and quality of life.

Indexed as

Nonmotor symptomsParkinson’s diseaseParkinson’s KinetiGraphRamadan

Identifiers

PMID41025303
PMCPMC12885638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.